INGN vs. COCH, CLGN, RBOT, SMTI, MLSS, LFWD, RENB, PRQR, SKYE, and INMB
Should you be buying Inogen stock or one of its competitors? The main competitors of Inogen include Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), Vicarious Surgical (RBOT), Sanara MedTech (SMTI), Milestone Scientific (MLSS), ReWalk Robotics (LFWD), Renovaro (RENB), ProQR Therapeutics (PRQR), Skye Bioscience (SKYE), and INmune Bio (INMB). These companies are all part of the "medical" sector.
Inogen (NASDAQ:INGN) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, community ranking, profitability, valuation and dividends.
Inogen received 383 more outperform votes than Envoy Medical when rated by MarketBeat users. However, 100.00% of users gave Envoy Medical an outperform vote while only 70.57% of users gave Inogen an outperform vote.
Inogen presently has a consensus target price of $7.50, suggesting a potential upside of 10.62%. Envoy Medical has a consensus target price of $6.00, suggesting a potential upside of 15.83%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts clearly believe Envoy Medical is more favorable than Inogen.
Inogen has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.68, meaning that its share price is 168% more volatile than the S&P 500.
Envoy Medical has a net margin of 0.00% compared to Inogen's net margin of -32.46%. Envoy Medical's return on equity of 0.00% beat Inogen's return on equity.
89.9% of Inogen shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 0.6% of Inogen shares are owned by insiders. Comparatively, 0.7% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, Envoy Medical had 4 more articles in the media than Inogen. MarketBeat recorded 5 mentions for Envoy Medical and 1 mentions for Inogen. Envoy Medical's average media sentiment score of 0.43 beat Inogen's score of -1.00 indicating that Envoy Medical is being referred to more favorably in the news media.
Envoy Medical has lower revenue, but higher earnings than Inogen.
Summary
Envoy Medical beats Inogen on 12 of the 16 factors compared between the two stocks.
Get Inogen News Delivered to You Automatically
Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
